The American Cancer Society predicts that nearly 50,000 Americans will die
from colon cancer this year.
Previous research has shown that those who take aspirin regularly have a
lower risk of colon cancer. A new study adds to this research, showing that
routine aspirin use may also extend the life of those already diagnosed.
Researchers followed over a thousand patients for ten years after they were
diagnosed and found that those who started taking aspirin regularly soon
after their diagnosis were 47% LESS likely to die from the disease than non-
users.
These findings suggest that the anti-inflammatory effects of aspirin may
have a preventive effect on colon cancer that increases the patient's chance
of survival.
Because long-term use of aspirin can cause ulcers and stomach bleeding,
further research is required before this treatment can be applied to colon
cancer patients.
Click here for more information.